Patient Preferences for Features Associated With Leadless Versus Conventional Transvenous Cardiac Pacemakers.

ABSTRACT:

Background

Regulatory approval of the first dual-chamber leadless pacemaker system provides patients an alternative to conventional transvenous pacemakers. The study objective was to quantify the preferences of patients for pacemaker features.

Methods

Patients with a de novo (ie, initial) pacemaker indication were recruited from 7 US sites to complete a Web-based discrete-choice experiment survey between May 11, 2022, and May 24, 2023. Patients chose between pairs of experimentally designed, hypothetical pacemakers that varied according to type (removable leadless, nonremovable leadless, or conventional transvenous); battery life (5, 8, 12, or 15 years); time since regulatory approval (2 or 10 years); discomfort for 6 months (none or discomfort); and complication risk and in

SUBMITTER: Reed SD 

PROVIDER: S-EPMC11654446 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature